logo
logo

Remilk™ Raises $120 Million In Series B Funding - Signaling Animal-Free Dairy At Scale Is Closer Than Ever

Jan 07, 2022•over 3 years ago

Amount Raised

$120 Million

Round Type

series b

Tel AvivHealth Care

Description

Remilk, an innovative food startup reimagining the dairy industry, has secured $120 million in Series B funding, led by NY-based Hanaco Ventures. The funding establishes Remilk as a primary player in the emerging cultivated dairy category and enables the Company to immediately scale production of its dairy-identical milk protein for commercial use by manufacturers in traditionally dairy-based products including cheeses, yogurt, and ice cream.

Company Information

Company

Remilk

Location

Tel Aviv, Tel Aviv District, Israel

About

Remilk is a global leader in the development of animal-free dairy. The company was founded by Aviv Wolff, an entrepreneur with experience at several startups, and Ori Cohavi, PhD in biochemistry, who has worked in R&D at a variety of biotech firms. They founded Remilk driven by a shared dedication to improving life on earth by learning from nature, while preserving it. Remilk produces dairy-identical milk proteins through a fermentation process and has developed a unique and patented approach to scalable manufacturing which dramatically increases efficiency in production, and, for the first time in history, eliminates the need for dairy cows in industrial-scale dairy production, without compromising on taste, functionality, or nutritional values. Remilk is real dairy, no cows. SOURCE Remilk

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech